Brandon Becker

1.4k total citations
41 papers, 982 citations indexed

About

Brandon Becker is a scholar working on Immunology, Clinical Psychology and Rheumatology. According to data from OpenAlex, Brandon Becker has authored 41 papers receiving a total of 982 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Clinical Psychology and 10 papers in Rheumatology. Recurrent topics in Brandon Becker's work include Psoriasis: Treatment and Pathogenesis (10 papers), Child and Adolescent Psychosocial and Emotional Development (8 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Brandon Becker is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (10 papers), Child and Adolescent Psychosocial and Emotional Development (8 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). Brandon Becker collaborates with scholars based in United States, United Kingdom and Germany. Brandon Becker's co-authors include Katherine B. Bevans, Robert C. Whitaker, Christopher B. Forrest, Rachel A. Gooze, Kathleen Cranley Gallagher, Carole A. Tucker, Allison N. Herman, Adam C. Carle, Rachel E. Teneralli and Lisa J. Meltzer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Brandon Becker

38 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brandon Becker United States	16	424	227	206	114	113	41	982
Astrīda S. Kaugars United States	15	287 0.7×	176 0.8×	78 0.4×	85 0.7×	109 1.0×	35	753
George Giannakopoulos Greece	19	426 1.0×	91 0.4×	157 0.8×	149 1.3×	61 0.5×	69	804
Jennifer Christofferson United States	13	288 0.7×	451 2.0×	115 0.6×	72 0.6×	91 0.8×	27	864
Erin M. Rodríguez United States	15	618 1.5×	654 2.9×	77 0.4×	160 1.4×	198 1.8×	47	1.4k
Cecelia Valrie United States	15	279 0.7×	517 2.3×	135 0.7×	119 1.0×	74 0.7×	41	1.1k
Paul Swamidhas Sudhakar Russell India	22	616 1.5×	264 1.2×	165 0.8×	162 1.4×	29 0.3×	105	1.6k
Madeleine J. Dunn United States	8	456 1.1×	541 2.4×	56 0.3×	99 0.9×	164 1.5×	9	963
Laura P. Richardson United States	14	495 1.2×	104 0.5×	73 0.4×	278 2.4×	184 1.6×	40	1.1k
Charles Keown‐Stoneman Canada	18	408 1.0×	99 0.4×	82 0.4×	141 1.2×	176 1.6×	88	1.1k
Pei‐Yoong Lam Canada	14	480 1.1×	140 0.6×	63 0.3×	61 0.5×	68 0.6×	27	1.1k

Countries citing papers authored by Brandon Becker

Since Specialization

Citations

This map shows the geographic impact of Brandon Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon Becker more than expected).

Fields of papers citing papers by Brandon Becker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon Becker. The network helps show where Brandon Becker may publish in the future.

Co-authorship network of co-authors of Brandon Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Brandon Becker. A scholar is included among the top collaborators of Brandon Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandon Becker. Brandon Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gold, Linda Stein, Michael Sebastian, Brandon Becker, et al.. (2025). Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 (TYK2) Inhibitor, in Patients with Moderate to Severe Scalp Psoriasis: Time to Meaningful Improvement in Patient-Reported Outcomes in a Phase 3b/4, Multicenter, Randomized, Double-blinded, Placebo-Controlled Study (PSORIATYK SCALP). SKIN The Journal of Cutaneous Medicine. 9(2). s533–s533.

Strand, Vibeke, Laure Gossec, Laura C. Coates, et al.. (2024). Improvements in Patient‐Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 Trial. Arthritis Care & Research. 76(8). 1139–1148. 1 indexed citations

Armstrong, April W., Matthias Augustin, Jennifer L. Beaumont, et al.. (2024). Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials. Dermatology and Therapy. 14(8). 2235–2248. 3 indexed citations

Zhong, Yichen, et al.. (2024). The Association Between Patient-Reported Disease Burden and Treatment Switching in Patients with Plaque Psoriasis Treated with Nonbiologic Systemic Therapy. PubMed. Volume 14. 167–174.

Mosca, Marta, Laurent Arnaud, Anca Askanase, et al.. (2023). LP-187 Abstract withdrawn. SHILAP Revista de lepidopterología. A158.2–A158. 1 indexed citations

Papp, Kim, Kenneth B. Gordon, Bruce Strober, et al.. (2023). Meaningful Change Thresholds for the Psoriasis Symptoms and Signs Diary. JAMA Dermatology. 160(2). 204–204. 3 indexed citations

Augustin, Matthias, Bruce Strober, April W. Armstrong, et al.. (2022). 35205 Deucravacitinib improves Dermatology Life Quality Index (DLQI) in patients with moderate to severe psoriasis: Results from the phase 3 POETYK PSO-1 and PSO-2 trials. Journal of the American Academy of Dermatology. 87(3). AB156–AB156. 2 indexed citations

Becker, Brandon, et al.. (2021). Qualitative and psychometric approaches to evaluate the PROMIS pain interference and sleep disturbance item banks for use in patients with rheumatoid arthritis. Journal of Patient-Reported Outcomes. 5(1). 52–52. 8 indexed citations

Becker, Brandon, Marguerite Bracher, Regina Rendas‐Baum, et al.. (2021). Development, psychometric evaluation and cognitive debriefing of the rheumatoid arthritis symptom and impact questionnaire (RASIQ). Journal of Patient-Reported Outcomes. 5(1). 129–129. 7 indexed citations

10.

Buckley, Christopher D., Jesus Abraham Simón Campos, Вячеслав Миколайович Ждан, et al.. (2020). Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging study. The Lancet Rheumatology. 2(11). e677–e688. 24 indexed citations

11.

Forrest, Christopher B., Katherine B. Bevans, Ania Filus, et al.. (2019). Assessing Children’s Eudaimonic Well-Being: The PROMIS Pediatric Meaning and Purpose Item Banks. Journal of Pediatric Psychology. 44(9). 1074–1082. 24 indexed citations

12.

Forrest, Christopher B., Lisa J. Meltzer, Carole L. Marcus, et al.. (2018). Development and validation of the PROMIS Pediatric Sleep Disturbance and Sleep-Related Impairment item banks. SLEEP. 41(6). 147 indexed citations

13.

Forrest, Christopher B., Janine Devine, Katherine B. Bevans, et al.. (2017). Development and psychometric evaluation of the PROMIS Pediatric Life Satisfaction item banks, child-report, and parent-proxy editions. Quality of Life Research. 27(1). 217–234. 31 indexed citations

14.

Forrest, Christopher B., Ulrike Ravens‐Sieberer, Janine Devine, et al.. (2017). Development and Evaluation of the PROMIS® Pediatric Positive Affect Item Bank, Child-Report and Parent-Proxy Editions. Journal of Happiness Studies. 19(3). 699–718. 42 indexed citations

15.

Becker, Brandon, Kathleen Cranley Gallagher, & Robert C. Whitaker. (2017). Teachers' dispositional mindfulness and the quality of their relationships with children in Head Start classrooms. Journal of School Psychology. 65. 40–53. 58 indexed citations

16.

Bevans, Katherine B., Anne W. Riley, Jeanne M. Landgraf, et al.. (2017). Children’s family experiences: development of the PROMIS® pediatric family relationships measures. Quality of Life Research. 26(11). 3011–3023. 47 indexed citations

17.

Forrest, Christopher B., Carole A. Tucker, Ulrike Ravens‐Sieberer, et al.. (2015). Concurrent validity of the PROMIS® pediatric global health measure. Quality of Life Research. 25(3). 739–751. 50 indexed citations

18.

Whitaker, Robert C., Tracy Dearth‐Wesley, Rachel A. Gooze, et al.. (2014). Adverse childhood experiences, dispositional mindfulness, and adult health. Preventive Medicine. 67. 147–153. 87 indexed citations

19.

Whitaker, Robert C., Brandon Becker, Allison N. Herman, & Rachel A. Gooze. (2013). The Physical and Mental Health of Head Start Staff: The Pennsylvania Head Start Staff Wellness Survey, 2012. Preventing Chronic Disease. 10. E181–E181. 129 indexed citations

20.

Kane, Sunanda V., William J. Sandborn, Brandon Becker, et al.. (2012). Natalizumab for moderate to severe Crohnʼs disease in clinical practice: The Mayo Clinic Rochester experience. Inflammatory Bowel Diseases. 18(12). 2203–2208. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact